Related Experiment Video
Updated: Jun 24, 2026

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation
Published on: January 10, 2025
Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does
1Cardioprotection Group, Hatter Cardiovascular Research Institute, Department of Medicine, Chris Barnard Building, Faculty of Health Sciences, University of Cape Town, 7925 Observatory, South Africa.
Insights
Tumor necrosis factor alpha (TNFα) paradoxically activates a novel cardiac protective pathway, the Survivor Activating Factor Enhancement (SAFE) pathway, reducing lethal reperfusion injury. This SAFE pathway, involving STAT-3, offers a new therapeutic target for acute myocardial infarction.
Area of Science:
- Cardiology
- Molecular Biology
- Cellular Signaling
Background:
- Lethal reperfusion injury is a significant complication of acute myocardial infarction treatment.
- The heart possesses intrinsic mechanisms to protect against reperfusion-induced cell death.
- Tumor necrosis factor alpha (TNFα) is typically associated with myocardial dysfunction.
Purpose of the Study:
- To review evidence for a novel protective pathway initiated by TNFα against reperfusion injury.
- To introduce the Survivor Activating Factor Enhancement (SAFE) pathway.
- To explore the SAFE pathway's interaction with the Reperfusion Injury Salvage Kinase (RISK) pathway and its therapeutic potential.
Main Methods:
- Review of existing scientific literature on TNFα, reperfusion injury, and cardiac signaling pathways.
- Analysis of evidence supporting the role of signal transducer and activator of transcription 3 (STAT-3) in cardioprotection.
- Comparison of the SAFE pathway with the established RISK pathway (involving Akt and Erk 1/2).
Main Results:
- TNFα can paradoxically activate a protective signaling cascade, the SAFE pathway.
- The SAFE pathway requires STAT-3 activation and limits cardiomyocyte death during reperfusion.
- The SAFE pathway operates independently of the RISK pathway.
Conclusions:
- The SAFE pathway represents a novel intrinsic cardiac protection mechanism against lethal reperfusion injury.
- Understanding the SAFE pathway's interplay with the RISK pathway is crucial for therapeutic development.
- Targeting the SAFE pathway holds potential for protecting hearts from reperfusion damage in clinical settings.
Abstract:
Lethal reperfusion injury is now recognized as a major limitation of current reperfusion therapy by primary percutaneous coronary intervention for acute myocardial infarction. Interestingly, the heart itself is capable of activating an intrinsic protective signaling programme to limit cell death during reperfusion. Tumor necrosis factor alpha (TNFalpha) is a cytokine generally thought to contribute to myocardial dysfunction in ischemia/reperfusion or heart failure. We review evidence that TNFalpha can paradoxically initiate the activation of a novel protective pathway against reperfusion injuries that we have named the Survivor Activating Factor Enhancement (SAFE) pathway. This path requires the activation of the signal transducer and activator of transcription 3 (STAT-3) and it can successfully lessen cardiomyocyte death at the time of reperfusion, independently of the activation of the already well-described Reperfusion Injury Salvage Kinase (RISK) pathway (which includes activation of Akt and Erk 1/2). Emerging knowledge on this novel protective path is presented here with the aim of unravelling its interaction with the RISK pathway and its potential human application to protect against lethal reperfusion injury.
Related Concept Videos
The Extrinsic Apoptotic Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Intrinsic Apoptotic Pathway
MAPK Signaling Cascades
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
